Coronary thrombolysis in women.
Coronary thrombolysis in women.
复制标题
女性冠状动脉溶栓。
DOI：
--
复制
发表时间：
1990
期刊：
影响因子：
--
通讯作者：
R. Becker
中科院分区：
文献类型：
--
作者：
R. Becker
急性心肌梗死(AMI)是全世界发病率和死亡率的主要原因。尽管急性心肌梗死在男性中的发病率高于女性，但仅在美国，每年就有超过25万名女性死于急性心肌梗死。冠状动脉溶栓治疗是急性心肌梗死的首选治疗方法，可降低男性和女性的死亡率。然而，女性的绝对受益可能较少，此外，在脑梗塞后早期阶段可能无法维持。出血并发症，包括颅内出血，可能在女性中更常见，特别是65岁以上的女性。作者综述了女性冠状动脉溶栓治疗的研究课题。
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality throughout the world. Although the incidence of AMI is higher in men than women, it is responsible for more than 250,000 annual deaths among women within the United States alone. Coronary thrombolysis is the treatment of choice for AMI and reduces mortality rates in both men and women. However, the absolute benefit may be less in women and, in addition, may not be maintained beyond the early postinfarction period. Bleeding complications, including intracranial hemorrhage, may be more common in women, particularly those more than 65 years of age. The author reviews the topic of coronary thrombolysis in women.